Clinical AI search company Vera Health announced a $28.5 million Series A on 27 October 2026, as reported by Tech.eu. Threshold Ventures led the round. Optum Ventures, the venture arm backed by UnitedHealth Group, joined alongside Mantis VC and SV Angel. Existing investors Y Combinator and Gradient increased their stakes, and total funding now stands at $32 million.
What the product does
Vera searches more than 60 million publications, clinical guidelines and drug labels, then weighs the evidence before it writes an answer. Each claim links to its supporting research and is colour-coded by strength of evidence. Where studies or national guidelines conflict, the system shows the disagreement and which guidance applies locally. The company says it is HIPAA- and GDPR-compliant and SOC 2 Type II certified.
The source reports more than 800,000 clinicians in 190 countries, with a team that grew from six to 12 people. Much of the growth came through physician referrals.
How it makes money
Licensed clinicians and medical trainees use Vera free of charge, and the company says that will not change. Revenue comes from institutions: once many of a hospital's staff use it daily, the hospital pays for a more tailored, more deeply integrated version. Through Vera Spaces, health systems can add their own clinical protocols next to national guidelines. The company runs no ads, and says partners such as medical societies and publishers cannot buy placement or alter an answer. The American College of Emergency Physicians' clinical policies are now available inside Vera with attribution.
Where the money goes
The funds are earmarked for evidence infrastructure, international expansion, partnerships and deeper local-guideline support. Europe is a priority, and the company has made its first European hire in Berlin, with more countries planned.
What is unverified
Usage figures and the quality-control claims, including daily AI-based evaluation of real responses with escalation to a human, come from the company through the interview. The source offers no independent audit.
Top comments (0)